Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Qilu Pharmaceutical Research And Development Center Ltd

Clinical trials sponsored by Shanghai Qilu Pharmaceutical Research And Development Center Ltd, explained in plain language.

Not yet recruiting 1

New hope for Hard-to-Treat cancers: experimental drug QLS1317 enters human trials

Disease control Not yet recruiting

This early-stage trial is testing a new drug called QLS1317 in 120 people with advanced solid tumors that have high microsatellite instability (MSI-H) or deficient DNA mismatch repair (dMMR). These patients have already tried standard treatments without success. The study aims to…

Phase: PHASE1 • Sponsor: Shanghai Qilu Pharmaceutical Research and Development Center LTD • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC